These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30710562)

  • 1. Optimisation, harmonisation and standardisation of the direct mycobacterial growth inhibition assay using cryopreserved human peripheral blood mononuclear cells.
    Tanner R; Smith SG; van Meijgaarden KE; Giannoni F; Wilkie M; Gabriele L; Palma C; Dockrell HM; Ottenhoff THM; McShane H
    J Immunol Methods; 2019 Jun; 469():1-10. PubMed ID: 30710562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tools for Assessing the Protective Efficacy of TB Vaccines in Humans:
    Tanner R; Satti I; Harris SA; O'Shea MK; Cizmeci D; O'Connor D; Chomka A; Matsumiya M; Wittenberg R; Minassian AM; Meyer J; Fletcher HA; McShane H
    Front Immunol; 2019; 10():2983. PubMed ID: 31998295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates.
    Tanner R; White AD; Boot C; Sombroek CC; O'Shea MK; Wright D; Hoogkamer E; Bitencourt J; Harris SA; Sarfas C; Wittenberg R; Satti I; Fletcher HA; Verreck FAW; Sharpe SA; McShane H
    NPJ Vaccines; 2021 Jan; 6(1):3. PubMed ID: 33397986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis.
    Zelmer A; Tanner R; Stylianou E; Damelang T; Morris S; Izzo A; Williams A; Sharpe S; Pepponi I; Walker B; Hokey DA; McShane H; Brennan M; Fletcher H
    BMC Infect Dis; 2016 Aug; 16():412. PubMed ID: 27519524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The
    Tanner R; Hoogkamer E; Bitencourt J; White A; Boot C; Sombroek CC; Harris SA; O'Shea MK; Wright D; Wittenberg R; Sarfas C; Satti I; Verreck FAW; Sharpe SA; Fletcher HA; McShane H
    F1000Res; 2021; 10():257. PubMed ID: 33976866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.
    Fletcher HA; Tanner R; Wallis RS; Meyer J; Manjaly ZR; Harris S; Satti I; Silver RF; Hoft D; Kampmann B; Walker KB; Dockrell HM; Fruth U; Barker L; Brennan MJ; McShane H
    Clin Vaccine Immunol; 2013 Nov; 20(11):1683-9. PubMed ID: 23986316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyfunctional CD4 T-cells correlate with in vitro mycobacterial growth inhibition following Mycobacterium bovis BCG-vaccination of infants.
    Smith SG; Zelmer A; Blitz R; Fletcher HA; Dockrell HM
    Vaccine; 2016 Oct; 34(44):5298-5305. PubMed ID: 27622301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cross-Species Mycobacterial Growth Inhibition Assay (MGIA) Project, 2010-2014.
    Brennan MJ; Tanner R; Morris S; Scriba TJ; Achkar JM; Zelmer A; Hokey DA; Izzo A; Sharpe S; Williams A; Penn-Nicholson A; Erasmus M; Stylianou E; Hoft DF; McShane H; Fletcher HA
    Clin Vaccine Immunol; 2017 Sep; 24(9):. PubMed ID: 28701467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple Mycobacterium tuberculosis complex strains.
    Painter H; Willcocks S; Zelmer A; Reljic R; Tanner R; Fletcher H
    Tuberculosis (Edinb); 2024 May; 146():102494. PubMed ID: 38367368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and application of the direct mycobacterial growth inhibition assay: a systematic review.
    Painter H; Harriss E; Fletcher HA; McShane H; Tanner R
    Front Immunol; 2024; 15():1355983. PubMed ID: 38380319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays.
    Tanner R; O'Shea MK; White AD; Müller J; Harrington-Kandt R; Matsumiya M; Dennis MJ; Parizotto EA; Harris S; Stylianou E; Naranbhai V; Bettencourt P; Drakesmith H; Sharpe S; Fletcher HA; McShane H
    Sci Rep; 2017 Mar; 7():43478. PubMed ID: 28256545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy.
    Tanner R; O'Shea MK; Fletcher HA; McShane H
    Vaccine; 2016 Sep; 34(39):4656-4665. PubMed ID: 27527814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development.
    Pepponi I; Khatri B; Tanner R; Villarreal-Ramos B; Vordermeier M; McShane H
    Tuberculosis (Edinb); 2017 Sep; 106():118-122. PubMed ID: 28802398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis.
    Jensen C; Lindebo Holm L; Svensson E; Aagaard C; Ruhwald M
    Sci Rep; 2017 Jun; 7(1):2830. PubMed ID: 28588268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85A.
    Tanner R; Kakalacheva K; Miller E; Pathan AA; Chalk R; Sander CR; Scriba T; Tameris M; Hawkridge T; Mahomed H; Hussey G; Hanekom W; Checkley A; McShane H; Fletcher HA
    BMC Infect Dis; 2014 Dec; 14():660. PubMed ID: 25466778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RUTI Vaccination Enhances Inhibition of Mycobacterial Growth
    Prabowo SA; Painter H; Zelmer A; Smith SG; Seifert K; Amat M; Cardona PJ; Fletcher HA
    Front Immunol; 2019; 10():894. PubMed ID: 31114572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mycobacterial growth inhibition assay employing live-cell imaging of virulent M. tuberculosis and monitoring of host cell viability.
    Andersson B; Nordvall MJ; Welin A; Lerm M; Schön T
    Tuberculosis (Edinb); 2020 Sep; 124():101977. PubMed ID: 32829078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant bacille Calmette-Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis.
    Chen YY; Lin CW; Huang WF; Chang JR; Su IJ; Hsu CH; Cheng HY; Hsu SC; Dou HY
    J Microbiol Immunol Infect; 2017 Feb; 50(1):90-96. PubMed ID: 25732698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of mycobacterial antigen-induced proliferation and interferon-gamma responses in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy.
    Al-Attiyah R; Mustafa AS; Abal AT; Madi NM; Andersen P
    FEMS Immunol Med Microbiol; 2003 Oct; 38(3):249-56. PubMed ID: 14522460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concordant proficiency in measurement of T-cell immunity in human immunodeficiency virus vaccine clinical trials by peripheral blood mononuclear cell and enzyme-linked immunospot assays in laboratories from three continents.
    Boaz MJ; Hayes P; Tarragona T; Seamons L; Cooper A; Birungi J; Kitandwe P; Semaganda A; Kaleebu P; Stevens G; Anzala O; Farah B; Ogola S; Indangasi J; Mhlanga P; Van Eeden M; Thakar M; Pujari A; Mishra S; Goonetilleke N; Moore S; Mahmoud A; Sathyamoorthy P; Mahalingam J; Narayanan PR; Ramanathan VD; Cox JH; Dally L; Gill DK; Gilmour J
    Clin Vaccine Immunol; 2009 Feb; 16(2):147-55. PubMed ID: 19091991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.